Advanced in Familial Partial Lipodystrophy

Uberto Pagotto

Bologna, IT 
Advanced in Familial Partial Lipodystrophy
Bologna, IT 
OverviewLocationsClinical Research

Overview

Uberto Pagotto practices in Bologna, Italy. Pagotto is rated as an Advanced expert by MediFind in the treatment of Familial Partial Lipodystrophy. Their top areas of expertise are Obesity, Intersex, Ovarian Cysts, Hormone Replacement Therapy (HRT), and Parathyroidectomy.

Their clinical research consists of co-authoring 162 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Familial Partial Lipodystrophy.

Locations

Bologna, Italy
Other Locations
Alma, Italy
Sant'orsola, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
View 1 Less Clinical Trial

162 Total Publications

Correction: Development of the Italian clinical practice guideline on diagnosing and treating obesity in adults: scope and methodological aspects.
Correction: Development of the Italian clinical practice guideline on diagnosing and treating obesity in adults: scope and methodological aspects.
Journal: Eating and weight disorders : EWD
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pagotto's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 16 Advanced Conditions
    View All 46 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile